$1.85
0.000.00%
At close: -
$1.83
-0.02-1.08%
After Hours: Dec 20, 4:04 PM EDT
Comments
Loading...
Taysha Gene Therapies (NASDAQ:TSHA) Stock, Earnings Estimates, EPS, And Revenue
Taysha Gene Therapies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 13
EPS
$-0.100
Quarterly Revenue
$1.8M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$9.9M
Analyze the earnings history of Taysha Gene Therapies using advanced sorting and filters.
Data brought to you by Benzinga APIs
Taysha Gene Therapies (TSHA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-13 | $-0.10 | $-0.09 | -11.1 % |
| Jun 2024 | 2024-08-12 | $-0.09 | $-0.17 | 47.1 % |
| Mar 2024 | 2024-05-14 | $-0.10 | $-0.11 | 9.09 % |
| Dec 2023 | 2024-03-19 | $0.92 | $-0.11 | 936.4 % |
Taysha Gene Therapies (TSHA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-13 | $1.79M | $1.65M | 8.36 % |
| Jun 2024 | 2024-08-12 | $1.11M | $2.66M | -58.2 % |
| Mar 2024 | 2024-05-14 | $3.41M | $2.56M | 33.2 % |
| Dec 2023 | 2024-03-19 | $3.60M | $2.65M | 36.0 % |
FAQ
When is Taysha Gene Therapies (NASDAQ:TSHA) reporting earnings?
Taysha Gene Therapies (TSHA) is scheduled to report earnings on March 18, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Taysha Gene Therapies (NASDAQ:TSHA)?
The Actual EPS was $-0.10, which missed the estimate of $-0.09.
What were Taysha Gene Therapies’s (NASDAQ:TSHA) revenues?
The Actual Revenue was $1.8M, which beat the estimate of $1.6M.
Browse earnings estimates, EPS, and revenue on all stocks.